ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.65
0.48%
US Tech 100
18,318.00
0.95%
S&P 500
5,304.72
0.70%
US Dollar vs CAD
1.36775
0.00%
Bitcoin
68,687.45
0.24%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Sirna Therapeutics (RNAI)

  7. Sirna Therapeutics (RNAI) News

RNAI

Sirna Therapeutics (RNAI)

Sirna Therapeutics
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RNAI
DateTimeSourceHeadlineSymbolCompany
01/03/20087:00AMMarketwiredBoston-Power(R) Fuels Next Stage of Growth With One of the Largest Portable Power Venture InvestmentsNASDAQ:RNAISirna Therapeutics
12/28/20062:00PMPR Newswire (US)Sirna Therapeutics Shareholders Approve Acquisition by Merck & Co.NASDAQ:RNAISirna Therapeutics
12/28/20062:00PMPR Newswire (US)Sirna Therapeutics Shareholders Approve Acquisition by Merck & Co.NASDAQ:RNAISirna Therapeutics
12/14/20067:38AMBusiness WireMerck & Co. and Sirna Therapeutics Announce Expiration of Hart-Scott-Rodino Waiting Period for the Proposed Acquisition of SirnaNASDAQ:RNAISirna Therapeutics
11/13/20063:36PMPR Newswire (US)Sirna Therapeutics Reports Third Quarter 2006 Financial ResultsNASDAQ:RNAISirna Therapeutics
10/30/20063:35PMBusiness WireMerck & Co., Inc. to Acquire Sirna Therapeutics, Inc.NASDAQ:RNAISirna Therapeutics
10/11/20069:00AMPR Newswire (US)Sirna Therapeutics to Present at 2006 BIO InvestorForumNASDAQ:RNAISirna Therapeutics
09/18/20062:19PMPR Newswire (US)Sirna Therapeutics to Present at UBS Global Life Sciences ConferenceNASDAQ:RNAISirna Therapeutics
09/08/20063:00PMPR Newswire (US)Sirna Therapeutics to Present at BioJapan 2006 World Business ForumNASDAQ:RNAISirna Therapeutics
08/31/20064:30PMPR Newswire (US)Sirna Therapeutics to Present at Two Upcoming ConferencesNASDAQ:RNAISirna Therapeutics
08/14/20064:04PMPR Newswire (US)Sirna Therapeutics Reports Second Quarter 2006 Financial ResultsNASDAQ:RNAISirna Therapeutics
08/10/20068:19AMPR Newswire (US)Sirna Therapeutics Reports Final Results from Phase 1 Study on Its RNAi-Based Therapeutic for Age-Related Macular DegenerationNASDAQ:RNAISirna Therapeutics
08/07/20065:25PMPR Newswire (US)Sirna Therapeutics to Report Second Quarter 2006 Financial Results on August 14, 2006NASDAQ:RNAISirna Therapeutics
08/03/20068:07AMPR Newswire (US)Sirna Therapeutics to Present at Bank of America 2006 Specialty Pharmaceuticals ConferenceNASDAQ:RNAISirna Therapeutics
07/06/20068:11AMPR Newswire (US)Sirna Therapeutics Joins Russell 3000 IndexNASDAQ:RNAISirna Therapeutics
07/05/20068:11AMPR Newswire (US)Sirna Therapeutics to Present at the C.E. Unterberg, Towbin Emerging Growth ConferenceNASDAQ:RNAISirna Therapeutics
06/23/20068:26AMPR Newswire (US)European Patent Office Significantly Limits Scope of Kreutzer-Limmer RNAi Patent ClaimNASDAQ:RNAISirna Therapeutics
06/08/20068:00AMPR Newswire (US)Sirna Therapeutics to Webcast Presentation at the Needham & Company Biotechnology and Medical Technology ConferenceNASDAQ:RNAISirna Therapeutics
05/30/20067:03AMPR Newswire (US)Sirna Therapeutics Announces Exercise of Over-Allotment Option By UnderwritersNASDAQ:RNAISirna Therapeutics
05/24/20066:14AMPR Newswire (US)Sirna Therapeutics Announces Pricing of Common Stock OfferingNASDAQ:RNAISirna Therapeutics
05/15/20066:13AMPR Newswire (US)Sirna Therapeutics Announces Public Offering of Common StockNASDAQ:RNAISirna Therapeutics
05/10/20068:20AMPR Newswire (US)Sirna Therapeutics Licenses Worldwide Exclusive Rights to microRNA Technology from University of Massachusetts Medical SchoolNASDAQ:RNAISirna Therapeutics
05/04/20067:36AMPR Newswire (US)Sirna Therapeutics Announces Programs in Strategic Research Alliance With GlaxoSmithKlineNASDAQ:RNAISirna Therapeutics
05/02/20067:36AMPR Newswire (US)Sirna Therapeutics Reports First Quarter 2006 Financial ResultsNASDAQ:RNAISirna Therapeutics
04/26/20067:08AMPR Newswire (US)Sirna Therapeutics to Report First Quarter 2006 Financial Results on May 2, 2006NASDAQ:RNAISirna Therapeutics
04/20/20067:02AMPR Newswire (US)Sirna Therapeutics to Webcast Presentation at the UBS Global Specialty Pharmaceuticals ConferenceNASDAQ:RNAISirna Therapeutics
04/03/20068:38AMPR Newswire (US)Sirna Therapeutics Granted First Broad siRNA Patent for a Gene Target in the United StatesNASDAQ:RNAISirna Therapeutics
04/03/20068:32AMPR Newswire (US)GlaxoSmithKline and Sirna Therapeutics Announce Major Alliance in RNAi-Based Therapeutics for Respiratory DiseaseNASDAQ:RNAISirna Therapeutics
03/28/20066:45PMPR Newswire (US)Sirna Therapeutics to Webcast Presentation at the CIBC World Markets Biotechnology & Specialty Pharmaceuticals ConferenceNASDAQ:RNAISirna Therapeutics
03/14/20067:37AMPR Newswire (US)Sirna Therapeutics Announces Its Scientific Advisory BoardNASDAQ:RNAISirna Therapeutics
 Showing the most relevant articles for your search:NASDAQ:RNAI

Your Recent History

USOTC
CNNA
Cann American (CE)
USOTC
DPLS
DarkPulse (PK)
USOTC
UBQU
Ubiquitech Software (PK)
USOTC
BMXI
Brookmount Explorations (PK)
USOTC
CYDY
CytoDyn (QB)
NASDAQ
AGBA
AGBA
USOTC
AHRO
Authentic (CE)
USOTC
BIEL
Bioelectronics (PK)
AMEX
SPY
SPDR S&P 500
USOTC
SHMP
NaturalShrimp (QB)
USOTC
AESO
Atlantic Energy Solutions (PK)
NASDAQ
RNAZ
TransCode Therapeutics
USOTC
YCRM
Yuenglings Ice Cream (PK)
USOTC
CATV
4Cable TV (PK)
USOTC
NLST
Netlist (QB)
NASDAQ
NB
NioCorp Developments
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved